Telix Pharmaceuticals Limited (TLPPF) Wednesday announced its initial public offering of 17 million American Depositary Shares (ADSs) in the U.S., each representing one ordinary share of Telix.
Telix expects gross proceeds of $200 million from the offering. Additionally, Telix intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the number of ADSs.
Jefferies, Morgan Stanley, Truist Securities and William Blair are acting as joint book-running managers for the offering.
Telix said it has applied to list its ADS on the Nasdaq under the ticker symbol TLX.
For comments and feedback: editorial@rttnews.com